Eight genes are highly associated with BMD variation in postmenopausal Caucasian women

Bone

Volumn 46, Issue 3, 2010, Pages 604-612

  Reppe, Sjur ^a,c   Refvem, Hilde ^b   Gautvik, Vigdis T ^a   Olstad, Ole K ^c   Høvring, Per I ^a,c   Reinholt, Finn P ^a   Holden, Marit ^d   Frigessi, Arnoldo ^a,d   Jemtland, Rune ^e   Gautvik, Kaare M ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b Lovisenberg Deacon Hospital   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN COMPUTING CENTER   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

BMD; Bone; Gene expression profiling; Osteoporosis; Postmenopausal women

Indexed keywords

ABC TRANSPORTER G1; CARRIER PROTEIN; CHROMOSOME 1 OPEN READING FRAME 61 PROTEIN; CHROMOSOME PROTEIN; DELETED IN LYMPHOCYTIC LEUKEMIA PROTEIN 2; DICKKOPF 1 PROTEIN; LONG CHAIN FATTY ACID COENZYME A LIGASE; NIPSNAP HOMOLOG 3B PROTEIN; ONCOPROTEIN; SCLEROSTIN; UNCLASSIFIED DRUG; GENETIC MARKER;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; CAUCASIAN; CLINICAL ARTICLE; FEMALE; FRACTURE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; MORPHOMETRICS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; COHORT ANALYSIS; COMPARATIVE STUDY; DNA MICROARRAY; GENETIC MARKER; GENETIC VARIABILITY; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; POSTMENOPAUSE OSTEOPOROSIS; VERY ELDERLY;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; BONE DENSITY; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GENETIC VARIATION; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE;

EID: 77649179580     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.11.007     Document Type: Article

References (41)

1. Cooper C. The crippling consequences of fractures and their impact on quality of life. Am. J. Med. 1997, 103:12S-17S.
2. O'Neill T.W., Felsenberg D., Varlow J., Cooper C., Kanis J.A., Silman A.J. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J. Bone Miner. Res. 1996, 11:1010-1018.
3. Ettinger B., Black D.M., Nevitt M.C., Rundle A.C., Cauley J.A., Cummings S.R., et al. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 1992, 7:449-456.
4. Lips P., Cooper C., Agnusdei D., Caulin F., Egger P., Johnell O., et al. Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis. Osteoporos. Int. 1997, 7:36-38.
5. Magaziner J., Lydick E., Hawkes W., Fox K.M., Zimmerman S.I., Epstein R.S., et al. Excess mortality attributable to hip fracture in white women aged 70 years and older. Am. J. Public Health 1997, 87:1630-1636.
6. Styrkarsdottir U., Halldorsson B.V., Gretarsdottir S., Gudbjartsson D.F., Walters G.B., Ingvarsson T., et al. New sequence variants associated with bone mineral density. Nat. Genet. 2009, 41:15-17.
7. Styrkarsdottir U., Halldorsson B.V., Gretarsdottir S., Gudbjartsson D.F., Walters G.B., Ingvarsson T., et al. Multiple genetic loci for bone mineral density and fractures. N. Engl. J. Med. 2008, 358:2355-2365.
8. Sigurdsson G., Halldorsson B.V., Styrkarsdottir U., Kristjansson K., Stefansson K. Impact of genetics on low bone mass in adults. J. Bone Miner. Res. 2008, 23:1584-1590.
9. Hopwood B., Tsykin A., Findlay D.M., Fazzalari N.L. Gene expression profile of the bone microenvironment in human fragility fracture bone. Bone 2009, 44:87-101.
10. Balla B., Kosa J.P., Kiss J., Borsy A., Podani J., Takacs I., et al. Different gene expression patterns in the bone tissue of aging postmenopausal osteoporotic and non-osteoporotic women. Calcif. Tissue Int. 2008, 82:12-26.
11. Balla B., Kosa J.P., Kiss J., Podani J., Takacs I., Lazary A., et al. Transcriptional profiling of immune system-related genes in postmenopausal osteoporotic versus non-osteoporotic human bone tissue. Clin. Immunol. 2009, 131:354-359.
12. Falch J.A., Meyer H.E. Osteoporosis and fractures in Norway. Occurrence and risk factors. Tidsskr. Nor. Laegeforen 1998, 118:568-572.
13. Reppe S., Stilgren L., Olstad O.K., Brixen K., Nissen-Meyer L.S., Gautvik K.M., et al. Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism. Bone 2006, 39:189-198.
14. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B. 2008, 57:289-300.
15. Benjamini Y., Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann. Statist. 2001, 29:1165-1188.
16. Kogianni G., Noble B.S. The biology of osteocytes. Curr. Osteoporos. Rep. 2007, 5:81-86.
17. Zhang J., Feuk L., Duggan G.E., Khaja R., Scherer S.W. Development of bioinformatics resources for display and analysis of copy number and other structural variants in the human genome. Cytogenet. Genome Res. 2006, 115:205-214.
18. Reppe S., Stilgren L., Abrahamsen B., Olstad O.K., Cero F., Brixen K., et al. Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E1465-E1473.
19. Xiao P., Chen Y., Jiang H., Liu Y.Z., Pan F., Yang T.L., et al. In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis. J. Bone Miner. Res. 2008, 23:644-654.
20. Hirschhorn J.N., Gennari L. Bona fide genetic associations with bone mineral density. N. Engl. J. Med. 2008, 358:2403-2405.
21. Richards J.B., Rivadeneira F., Inouye M., Pastinen T.M., Soranzo N., Wilson S.G., et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008, 371:1505-1512.
22. Sims A.M., Shephard N., Carter K., Doan T., Dowling A., Duncan E.L., et al. Genetic analyses in a sample of individuals with high or low BMD shows association with multiple Wnt pathway genes. J. Bone Miner. Res. 2008, 23:499-506.
23. Liu Y.J., Shen H., Xiao P., Xiong D.H., Li L.H., Recker R.R., et al. Molecular genetic studies of gene identification for osteoporosis: a 2004 update. J. Bone Miner. Res. 2006, 21:1511-1535.
24. Xiong Q., Jiao Y., Hasty K.A., Canale S.T., Stuart J.M., Beamer W.G., et al. Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse. Genomics 2009, 93:401-414.
25. Semenov M., Tamai K., He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem. 2005, 280:26770-26775.
26. MacDonald B.T., Joiner D.M., Oyserman S.M., Sharma P., Goldstein S.A., He X., et al. Bone mass is inversely proportional to Dkk1 levels in mice. Bone 2007, 41:331-339.
27. Pinzone J.J., Hall B.M., Thudi N.K., Vonau M., Qiang Y.W., Rosol T.J., et al. The role of Dickkopf-1 in bone development, homeostasis and disease. Blood 2009, 113:517-525.
28. Glass D.A., Karsenty G. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. Curr. Top. Dev. Biol. 2006, 73:43-84. 43-84.
29. Kim W.S., Weickert C.S., Garner B. Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J. Neurochem. 2008, 104:1145-1166.
30. Buechler C., Bodzioch M., Bared S.M., Sigruener A., Boettcher A., Lapicka-Bodzioch K., et al. Expression pattern and raft association of NIPSNAP3 and NIPSNAP4, highly homologous proteins encoded by genes in close proximity to the ATP-binding cassette transporter A1. Genomics 2004, 83:1116-1124.
31. Yao H., Ye J. Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J. Biol. Chem. 2008, 283:849-854.
32. Chung E.Y., Dews M., Cozma D., Yu D., Wentzel E.A., Chang T.C., et al. c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. Cancer Biol. Ther. 2008, 7:1758-1764.
33. Roccaro A.M., Sacco A., Thompson B., Leleu X., Azab A.K., Azab F., et al. microRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood 2009, 113:6669-6680.
34. Hayashibara T., Hiraga T., Yi B., Nomizu M., Kumagai Y., Nishimura R., et al. A synthetic peptide fragment of human MEPE stimulates new bone formation in vitro and in vivo. J. Bone Miner. Res. 2004, 19:455-462.
35. Jain A., Fedarko N.S., Collins M.T., Gelman R., Ankrom M.A., Tayback M., et al. Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density. J. Clin. Endocrinol. Metab. 2004, 89:4158-4161.
36. Winkler D.G., Sutherland M.S., Ojala E., Turcott E., Geoghegan J.C., Shpektor D., et al. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins. J. Biol. Chem. 2005, 280:2498-2502.
37. Sutherland M.K., Geoghegan J.C., Yu C., Turcott E., Skonier J.E., Winkler D.G., et al. Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation. Bone 2004, 35:828-835.
38. Leupin O., Kramer I., Collette N.M., Loots G.G., Natt F., Kneissel M., et al. Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J. Bone Miner. Res. 2007, 22:1957-1967.
39. Mullender M.G., Tan S.D., Vico L., Alexandre C., Klein-Nulend J. Differences in osteocyte density and bone histomorphometry between men and women and between healthy and osteoporotic subjects. Calcif. Tissue Int. 2005, 77:291-296.
40. Truong L., Fazzalari J., Kuliwaba J. Osteocyte apoptosis and expression of sclerostin in postmenopausal women with fragility hip fracture. J. Bone Miner. Res. 2009, 24(Suppl. 1). Ref Type: Abstract.
41. Lee D., Cho T., Lee H., Yoo W., Choi I. Endothelial progenitor cell mobilization during distraction osteogenesis in human. J. Bone Miner. Res. 2008, 33(Suppl. 1):Sa053. Ref Type: Abstract.